Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Obstructive Sleep Apnea/Hypopnea Syndrome.

Sanders1, Redline

  • 1University of Pittsburgh School of Medicine, 440 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261, USA.

Current Treatment Options in Neurology
|November 30, 2000
PubMed
Summary

Obstructive sleep apnea (OSA) management involves lifestyle changes and treatment based on severity. Continuous positive airway pressure (CPAP) is the primary therapy for OSA, improving sleep quality and health outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case of Albuminuria.

Glasgow medical journal·2018
Same author

Address to the Medico-Chirurgical Society of Edinburgh on January 7th.

Edinburgh medical journal·2018
Same author

Lipæmia and Fat Embolism in the Fatal Dyspnœa and Coma of Diabetes.

Edinburgh medical journal·2018
Same author

Journal search and commentary.

Sleep medicine·2001
Same author

Article reviewed: Morbidly obese patients with severe obstructive sleep apnea: is airway reconstructive surgery a viable treatment option?

Sleep medicine·2001
Same author

Disulfide-strapped porphyrins for monolayer formation on gold

Organic letters·2001

Area of Science:

  • Sleep Medicine
  • Pulmonology
  • Cardiovascular Health

Background:

  • Obstructive sleep apnea/hypopnea (OSA/H) is a prevalent disorder with diverse treatment modalities.
  • Lifestyle modifications are crucial for managing upper airway instability during sleep.
  • Treatment aggressiveness should align with the physiological and clinical severity of OSA/H.

Purpose of the Study:

  • To outline therapeutic options for obstructive sleep apnea/hypopnea.
  • To emphasize the importance of treating OSA/H to alleviate daytime sleepiness and hypoxemia.
  • To highlight the association between OSA/H and cardiovascular diseases, suggesting a lower threshold for treatment in at-risk patients.

Main Methods:

  • Assessment of OSA/H severity through its physiologic and clinical impact.
  • Initial trial of continuous positive airway pressure (CPAP) for all patients requiring treatment.
  • Evaluation of alternative therapies if CPAP is not tolerated long-term.

Main Results:

  • CPAP therapy offers rapid and reliable alleviation of OSA/H symptoms.
  • Non-positive pressure interventions cannot guarantee upper airway stabilization and may have adverse effects.
  • Patient education is vital for successful OSA/H management and improved quality of life.

Conclusions:

  • Continuous positive airway pressure (CPAP) is the recommended first-line treatment for obstructive sleep apnea/hypopnea.
  • While CPAP is highly effective, patient education and management of side effects are essential for long-term adherence and outcomes.
  • Early intervention for OSA/H, especially in patients with cardiovascular risk factors, is prudent due to strong disease associations.

Related Experiment Videos